TabsDetailsBasic DetailsDate Posted: Wednesday, January 9, 2013Status: CompleteMedical Product: duloxetine, milnacipran, pregabalinDescription: Modular program-based one-time assessment of the use of duloxetine, pregabalin, and milnacipranin the Mini-Sentinel Distributed Database. Modular programs are adaptable standardized programs. Queries were executed in October-November 2011.If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer. Read More Deliverables (1)Mini-Sentinel Modular Program Report: Duloxetine Pregabalin Milnacipran Use 1Additional InformationAdditional DetailsFDA Center: CDERTime Period: 2006 - 2010Study Type: Modular ProgramAssessment Type: Exploratory AnalysesData Sources: Mini-Sentinel Distributed Database (MSDD)
